Anton Iosifovich Orlov

Title: Anton Iosifovich Orlov: Innovator in Immunology and Biotechnology

Introduction

Anton Iosifovich Orlov is a notable inventor based in St. Petersburg, Russia. He has made significant contributions to the fields of immunology, biotechnology, and medicine. With a total of three patents to his name, Orlov's work focuses on developing innovative solutions for treating oncological diseases and preventing influenza.

Latest Patents

One of Orlov's latest patents is a humanized monoclonal antibody specific to syndecan-1. This invention relates to antitumor pharmaceuticals based on monoclonal antibodies and aims to create an efficient and safe universal antitumor agent. The proposed antibody, characterized by a specific combination of amino acid and nucleotide sequences, is designed for the therapy of tumor diseases. Additionally, Orlov has developed a polyvalent fusion protein vaccine against influenza. This vaccine contains antigenic determinants of influenza A and B viruses and is designed to provide universal protection against influenza strains.

Career Highlights

Throughout his career, Anton Iosifovich Orlov has worked with various companies, including Universal Biosystems Limited Company. His innovative work has positioned him as a key figure in the development of antitumor and antiviral therapies.

Collaborations

Orlov has collaborated with notable individuals in his field, including Ilya Vladimirovich Dukhovlinov and Mark Borisovich Balazovskiy. These collaborations have contributed to the advancement of his research and inventions.

Conclusion

Anton Iosifovich Orlov is a distinguished inventor whose work in immunology and biotechnology has the potential to significantly impact medical treatments. His innovative patents reflect his commitment to advancing healthcare solutions.